Kanut Laoharawee

497 total citations
25 papers, 357 citations indexed

About

Kanut Laoharawee is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Kanut Laoharawee has authored 25 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Physiology. Recurrent topics in Kanut Laoharawee's work include CRISPR and Genetic Engineering (14 papers), Virus-based gene therapy research (8 papers) and Lysosomal Storage Disorders Research (8 papers). Kanut Laoharawee is often cited by papers focused on CRISPR and Genetic Engineering (14 papers), Virus-based gene therapy research (8 papers) and Lysosomal Storage Disorders Research (8 papers). Kanut Laoharawee collaborates with scholars based in United States and United Kingdom. Kanut Laoharawee's co-authors include Branden S. Moriarity, Beau R. Webber, Walker S. Lahr, R. Scott McIvor, Kelly M. Podetz-Pedersen, Matthew J. Johnson, Tam T. T. N. Nguyen, Robert Radeke, Scott Sproul and Michael C. Holmes and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Kanut Laoharawee

24 papers receiving 351 citations

Peers

Countries citing papers authored by Kanut Laoharawee

Since Specialization

Citations

This map shows the geographic impact of Kanut Laoharawee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanut Laoharawee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanut Laoharawee more than expected).

Fields of papers citing papers by Kanut Laoharawee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanut Laoharawee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanut Laoharawee. The network helps show where Kanut Laoharawee may publish in the future.

Co-authorship network of co-authors of Kanut Laoharawee

This figure shows the co-authorship network connecting the top 25 collaborators of Kanut Laoharawee. A scholar is included among the top collaborators of Kanut Laoharawee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanut Laoharawee. Kanut Laoharawee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), (unknown), (unknown), Mitchell G. Kluesner, Emily J. Pomeroy, Joseph G. Skeate, Nicholas J. Slipek, Walker S. Lahr, (unknown), (unknown), Jason Bell, Kendell Clement, (unknown), Kanut Laoharawee, (unknown), Beau R. Webber, Branden S. Moriarity	8
2	Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders 2024 ·Molecular Therapy ·(unknown), Kanut Laoharawee, (unknown), (unknown), Nicholas J. Slipek, (unknown), M. J. Johnson, Beau R. Webber, Branden S. Moriarity	0
3	Prime Editing Enables Precise and Efficient Single Amino Acid Substitutions to Shield CD34+ Hematopoietic Stem Cells from Anti-CD117 Antibody-Based Conditioning 2024 ·Blood ·Jack Heath, (unknown), (unknown), (unknown), Kanut Laoharawee, (unknown), David P. Waterman, M. Roy, Seth C. Alexander, (unknown), (unknown), (unknown), Barrett J. Nehilla, (unknown), (unknown), Hetal Patel, (unknown), (unknown), Jeremy S. Duffield, Jennifer L. Gori	1
4	Development and testing of a versatile genome editing application reporter (V-GEAR) system 2024 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Kanut Laoharawee, Walker S. Lahr, (unknown), Joseph J. Peterson, Jason Bell, Beau R. Webber, Branden S. Moriarity	1
5	Generation and characterization of an immunodeficient mouse model of mucopolysaccharidosis type II 2023 ·Molecular Genetics and Metabolism ·(unknown), Lalitha R. Belur, (unknown), Kelly M. Podetz-Pedersen, (unknown), Kanut Laoharawee, (unknown), Troy C. Lund, Yun You, Davis Seelig, Beau R. Webber, R. Scott McIvor	1
6	Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome 2023 ·Molecular Genetics and Metabolism Reports ·Kanut Laoharawee, Kelly M. Podetz-Pedersen, Tam T. T. N. Nguyen, (unknown), (unknown), Lalitha R. Belur, Walter C. Low, Karen Kozarsky, R. Scott McIvor	5
7	Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction 2022 ·Human Gene Therapy ·Kelly M. Podetz-Pedersen, Kanut Laoharawee, (unknown), Tam T. T. N. Nguyen, (unknown), (unknown), Karen Kozarsky, R. Scott McIvor, Lalitha R. Belur	5
8	Primary B cell engineering for therapeutic research 2022 ·Trends in Molecular Medicine ·(unknown), Kanut Laoharawee, Branden S. Moriarity	3
9	Correction of Fanconi Anemia Mutations Using Digital Genome Engineering 2022 ·International Journal of Molecular Sciences ·(unknown), Mitchell G. Kluesner, (unknown), Walker S. Lahr, (unknown), (unknown), Anthony P. DeFeo, (unknown), Kanut Laoharawee, John E. Wagner, Margaret L. MacMillan, Gregory M. Vercellotti, Jakub Tolar, Mark J. Osborn, R. Scott McIvor, Beau R. Webber, Branden S. Moriarity	5
10	Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma 2020 ·Molecular Cancer Therapeutics ·Branden A. Smeester, (unknown), Nicholas J. Slipek, (unknown), Natalie Stratton, Emily J. Pomeroy, (unknown), Kenta Yamamoto, Kyle Williams, Kanut Laoharawee, (unknown), Juan E. Abrahante, Susan K. Rathe, Lauren J. Mills, (unknown), Wendy A. Hudson, Eric P. Rahrmann, David A. Largaespada, Branden S. Moriarity	13
11	PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma 2020 ·Bone ·Branden A. Smeester, Nicholas J. Slipek, Emily J. Pomeroy, Kanut Laoharawee, (unknown), (unknown), Kyle Williams, Natalie Stratton, Kenta Yamamoto, (unknown), Susan K. Rathe, Lauren J. Mills, Wendy A. Hudson, (unknown), (unknown), Eric P. Rahrmann, Branden S. Moriarity, David A. Largaespada	28
12	Genome Engineering of Primary Human B Cells Using CRISPR/Cas9 2020 ·Journal of Visualized Experiments ·Kanut Laoharawee, Matthew J. Johnson, Walker S. Lahr, (unknown), Beau R. Webber, Branden S. Moriarity	10
13	Genome Engineering of Primary Human B Cells Using CRISPR/Cas9 2020 ·Journal of Visualized Experiments ·Kanut Laoharawee, M. J. Johnson, Walker S. Lahr, Joseph J. Peterson, Beau R. Webber, Branden S. Moriarity	3
14	Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease 2018 ·Scientific Reports ·Matthew J. Johnson, Kanut Laoharawee, Walker S. Lahr, Beau R. Webber, Branden S. Moriarity	62
15	ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome 2018 ·Molecular Therapy ·Li Ou, Russell C. DeKelver, Michelle Rohde, Susan Tom, Robert Radeke, Susan S. Martin, Yolanda Santiago, Scott Sproul, (unknown), Brenda Koniar, Kelly M. Podetz-Pedersen, Kanut Laoharawee, (unknown), Kathleen Meyer, Michael C. Holmes, R. Scott McIvor, Thomas Wechsler, Chester B. Whitley	64
16	Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing 2018 ·Molecular Therapy ·Kanut Laoharawee, Russell C. DeKelver, Kelly M. Podetz-Pedersen, Michelle Rohde, Scott Sproul, (unknown), Tam T. T. N. Nguyen, Susan S. Martin, Li Ou, Susan Tom, Robert Radeke, Kathleen Meyer, Michael C. Holmes, Chester B. Whitley, Thomas Wechsler, R. Scott McIvor	91
17	Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System–Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer 2017 ·Human Gene Therapy ·Kanut Laoharawee, Kelly M. Podetz-Pedersen, Tam T. T. N. Nguyen, (unknown), Kelley F. Kitto, Zhenhong Nan, Carolyn A. Fairbanks, Walter C. Low, Karen Kozarsky, R. Scott McIvor	42
18	ZFN-mediated in vivo genome editing results in phenotypic correction in murine MPS I and MPS II models 2017 ·Molecular Genetics and Metabolism ·Russell C. DeKelver, Li Ou, Kanut Laoharawee, Susan Tom, Robert Radeke, Michelle Rohde, Scott Sproul, (unknown), Brenda Koniar, Kelly M. Podetz-Pedersen, (unknown), Michael C. Holmes, R. Scott McIvor, Chester B. Whitley, Thomas Wechsler	1
19	ZFN-mediated correction of murine MPS I model by expression of the human IDUA cDNA from the albumin “safe harbor” locus 2016 ·Molecular Genetics and Metabolism ·Li Ou, Russell C. DeKelver, Susan Tom, Robert Radeke, (unknown), Amy Manning-Bog, Scott Sproul, (unknown), Brenda Koniar, Kelly M. Podetz-Pedersen, Kanut Laoharawee, (unknown), Michael C. Holmes, Thomas Wechsler, R. Scott McIvor, Chester B. Whitley	1
20	479. ZFN-Mediated In Vivo Genome Editing Results in Supraphysiological Levels of Lysosomal Enzymes Deficient in Hunter and Hurler Syndrome and Gaucher Disease 2015 ·Molecular Therapy ·Thomas Wechsler, (unknown), Michelle Rohde, Susan Tom, Scott Sproul, (unknown), Kanut Laoharawee, Kelly M. Podetz-Pedersen, Chester B. Whitley, (unknown), Philip D. Gregory, Michael C. Holmes	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact